Worse survival and poorly differentiated tumours were correlated with lower SMA+ expression in patients with pancreatic ductal adenocarcinoma (PDAC).81 In contrast to the traditional view that CAFs promote tumour progression, this study found that the presence of myofibroblasts was correlated with immunotherapy and a better prognosis of PDAC patients. This evidence concerns the gene SMN1 and neoplasm.